Genocea Biosciences Inc (GNCAQ)

[scurve]

Yes. stuck my toe in again at $4.30. Most of my positions are under $4, but I think it will hold here. If it falls back to $3.83 or $3.50, i'll buy in again. Reading through the press releases, it seems phase 2 has gone well and Phase 3 is awaiting FDA approval. While they may have started out with hopes of a vaccine for HSV2, it looks like they'll end up with a much more efficient way of controlling it (a single shot every 6 months vs. taking a daily Valtrex pill). Will be interesting to see if GSK decides to buy them up or do some kind of collaborative tie in. Watch for when the shorts come due.